Pfizer, Inc. vs Veeva Systems Inc. — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
8.9
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
VEEV
Clean balance sheet with low leverage (0.0× debt-to-equity).
Analyst Consensus
HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $264.46 (+54.1%)
28 analysts
Fundamentals
PFE
VEEV
19.4×
Trailing P/E
31.5×
9.4×
Forward P/E
17.4×
12.4%
Profit Margin
28.4%
75.8%
Gross Margin
75.5%
8.9%
ROE
13.9%
-1.2%
Revenue Growth
16.0%
—
Earnings Growth
23.2%
0.39
Beta
1.10
—
Price / Book
—
$149.8B
Market Cap
$28.2B
$22 – $29
52-Week Range
$148 – $311
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →